Atlas Trials

Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer

Clinical trial NCT04289792 · UNKNOWN

Trial details

NCT number
NCT04289792
Sponsor
Fujian Medical University Union Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Neoplasms
Start date
2020-05-09
Primary completion
2024-05-09
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.